Replies to post #12296 on Titan Pharmaceuticals Inc (TTNP)

[Doctor Detroit]

Listened to the Cantor Fitzgerald Presentation...

1. Maybe he caught the red-eye or something, but Sunil sounds tired and beaten. Absolutely no energy.

2. Not much news

-so far, 90% of those who have gotten probuphine have elected to get a second implant.
-the maintenance market is about 30% of the buprenorphine market. Titan needs 20% of that 30% to reach $300 million a year in sales...which means 6% of the entire market.
-they will begin ropinrole testing possibly still this month (first cohort appears to have been enrolled). They estimate the phase 3 for ropinirole will require $30 million because they have to provide the FDA with at least 500 patients of safety data.